Steroid hormone synthetic pathways in prostate cancer

While androgen deprivation therapy (ADT) remains the primary treatment for metastatic prostate cancer (PCa) since the seminal recognition of the disease as androgen-dependent by Huggins and Hodges in 1941, therapy is uniformly marked by progression to castration-resistant prostate cancer (CRPC) over...

Descripción completa

Detalles Bibliográficos
Autor principal: Mostaghel, Elahe A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219921/
https://www.ncbi.nlm.nih.gov/pubmed/25379460
http://dx.doi.org/10.3978/j.issn.2223-4683.2013.09.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219921/
https://www.ncbi.nlm.nih.gov/pubmed/25379460
http://dx.doi.org/10.3978/j.issn.2223-4683.2013.09.16

Ejemplares similares